4D Molecular Therapeutics Inc (FDMT)vsRevolution Medicines Inc (RVMD)
FDMT
4D Molecular Therapeutics Inc
$8.64
-13.69%
HEALTHCARE · Cap: $451.67M
RVMD
Revolution Medicines Inc
$155.69
+3.11%
HEALTHCARE · Cap: $32.71B
Smart Verdict
WallStSmart Research — data-driven comparison
4D Molecular Therapeutics Inc generates 11792% more annual revenue ($88.24M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs -182.3%. FDMT earns a higher WallStSmart Score of 38/100 (F).
FDMT
Hold38
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Revenue surging 21664.0% year-over-year
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -35.6% — below average capital efficiency
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : FDMT
The strongest argument for FDMT centers on Price/Book, Revenue Growth, Debt/Equity. Revenue growth of 21664.0% demonstrates continued momentum.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : FDMT
The primary concerns for FDMT are EPS Growth, Market Cap, Piotroski F-Score.
Bear Case : RVMD
The primary concerns for RVMD are EPS Growth, Profit Margin, Operating Margin.
Key Dynamics to Monitor
FDMT profiles as a hypergrowth stock while RVMD is a value play — different risk/reward profiles.
FDMT carries more volatility with a beta of 2.76 — expect wider price swings.
FDMT is growing revenue faster at 21664.0% — sustainability is the question.
FDMT generates stronger free cash flow (-68M), providing more financial flexibility.
Bottom Line
FDMT scores higher overall (38/100 vs 24/100) and 21664.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
4D Molecular Therapeutics Inc
HEALTHCARE · BIOTECHNOLOGY · USA
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops candidate products using its adeno-associated virus vectors. The company is headquartered in Emeryville, California.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?